SCHEMBL659131

SCHEMBL659131

Nc1nccc2cc(-c3cnc4cnccn34)oc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 1/20 0.44
TAB1 Q15750 1/20 0.44
TLR8 Q9NR97 2/20 0.40
PRMT5 O14744 1/20 0.36
WDR77 Q9BQA1 1/20 0.36
HRH3 Q9Y5N1 1/20 0.35
MAPT P10636 1/20 0.34
MKNK1 Q9BUB5 6/20 0.33
HDAC1 Q13547 1/20 0.33
FGFR1 P11362 1/20 0.33
KDR P35968 2/20 0.33
PKM P14618 1/20 0.31
TTK P33981 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
ALOX15 P16050 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660875 0.79 MAP3K7 (0.50) MAP3K7TAB1PRMT5WDR77HRH3
SCHEMBL659026 0.67 RAB9A (0.58) MAP3K7TAB1TLR8MAPTKDM4E
SCHEMBL997527 0.67 PRMT5 (0.35) PRMT5WDR77HRH3MAPTHDAC1
SCHEMBL659522 0.67 QPCT (0.39) MAP3K7TAB1TLR8PRMT5WDR77
SCHEMBL660235 0.67 LMNA (0.44) MAP3K7TAB1TLR8MAPTKDM4E
SCHEMBL659979 0.66 TLR8 (0.40) MAP3K7TAB1TLR8MAPTKDR
SCHEMBL659267 0.66 MAP3K7 (0.49) MAP3K7TAB1TLR8MAPTKDR
SCHEMBL659236 0.66 TLR8 (0.40) MAP3K7TAB1TLR8MAPTKDR
SCHEMBL2663392 0.66 CHEK1 (0.50) PRMT5WDR77MKNK1KDR
SCHEMBL13494308 0.65 HDAC1 (0.39) PRMT5WDR77HRH3HDAC1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 MAP3K7 5/4885TAB1 4/4885TLR8 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.